Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 156 entries
View as:

A Phase IIa Study of KHK4563

Phase: N/A Priority: Normal
NCT ID: NCT01412736 Org: User:
Start: 08/31/11 End: 10/31/13 Due: 10/31/14

Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT02073981 Org: User:
Start: 03/31/14 End: 06/30/23 Due: 06/30/24

A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03957681 Org: User:
Start: 05/23/19 End: 04/30/25 Due: 04/30/26

A Study of LY2523355 in Patients With Solid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01358019 Org: User:
Start: 05/31/11 End: 01/31/13 Due: 01/31/14

Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00957203 Org: User:
Start: 10/31/09 End: 03/31/12 Due: 03/31/13

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

Phase: N/A Priority: Normal
NCT ID: NCT00199355 Org: User:
Start: 04/30/05 End: 03/31/06 Due: 03/31/07

A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia

Phase: N/A Priority: Normal
NCT ID: NCT03233126 Org: User:
Start: 07/06/17 End: 02/17/20 Due: 02/17/21

Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00775502 Org: User:
Start: 10/31/08 End: 10/31/11 Due: 10/31/12

Effect of External Heat on a Transdermal Granisetron Patch in Pharmacokinetics (PK) of Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01073696 Org: User:
Start: 03/31/10 End: 04/30/10 Due: 04/30/11

A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03096223 Org: User:
Start: 04/10/17 End: 02/07/18 Due: 02/07/19

Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06812104 Org: User:
Start: 10/10/24 End: 04/30/28 Due: 04/30/29

PK, Tolerability and Safety of the Co-administration of Sancuso® (Transdermal Granisetron) and IV Granisetron

Phase: N/A Priority: Normal
NCT ID: NCT00873197 Org: User:
Start: 04/30/09 End: 05/31/09 Due: 05/31/10

Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)

Phase: N/A Priority: Normal
NCT ID: NCT00890565 Org: User:
Start: 05/31/09 End: 09/30/09 Due: 09/30/10

A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01488201 Org: User:
Start: 11/30/11 End: 09/30/12 Due: 09/30/13

Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00955318 Org: User:
Start: 07/31/09 End: 03/31/12 Due: 03/31/13

Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners

Phase: N/A Priority: Normal
NCT ID: NCT03745521 Org: User:
Start: 05/01/18 End: 12/31/28 Due: 12/31/29

A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia

Phase: N/A Priority: Normal
NCT ID: NCT02181764 Org: User:
Start: 07/31/14 End: 06/30/15 Due: 06/30/16

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00838578 Org: User:
Start: 03/31/09 End: 10/31/12 Due: 10/31/13

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO

Phase: N/A Priority: Normal
NCT ID: NCT05357573 Org: User:
Start: 09/07/22 End: 12/22/23 Due: 12/22/24

A Study of KHK4827 in Subjects With Palmoplantar Pustulosis

Phase: N/A Priority: Normal
NCT ID: NCT04061252 Org: User:
Start: 08/10/19 End: 08/05/22 Due: 08/05/23

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01447732 Org: User:
Start: 10/31/11 End: 01/31/15 Due: 01/31/16

A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03830528 Org: User:
Start: 02/26/19 End: 10/10/19 Due: 10/10/20

An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron

Phase: N/A Priority: Normal
NCT ID: NCT00868764 Org: User:
Start: 04/30/09 End: 09/30/09 Due: 09/30/10

The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT02174250 Org: User:
Start: 06/30/14 End: 12/31/14 Due: 12/31/15

A Study of KRN23 in X-linked Hypophosphatemia

Phase: N/A Priority: Normal
NCT ID: NCT00830674 Org: User:
Start: 12/31/08 End: 05/31/13 Due: 05/31/14